Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 1Phase 2 1

Status

Completed 25Recruiting 15Active not recruiting 9Unknown 6Terminated 5Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 4OTHER_GOV 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 2Other hematologic neoplasm 1Head & Neck 1CNS 1

Conditions

Prostatic Neoplasms 2Thyroid Neoplasms 1Musculoskeletal Diseases 1Leukemia, Myeloid, Acute 1Glioma 1Disease 1Brain Neoplasms 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × Interventional × Congresses as Topic × Clear all
NCT04737577 2023-06-18

G-SUMIT

Sunnybrook Health Sciences Centre

Phase NA Unknown
72 enrolled
CNS

Brain Neoplasms, Glioma

NCT03454464 2018-09-18

Evaluation of Central Compartment Dissection Without Thyroidectomy

Fujian Medical University

Phase NA Unknown
100 enrolled
Head & Neck

Thyroid Neoplasms

NCT03453905 2018-03-05

ZYCTFEA

Tel-Aviv Sourasky Medical Center

Phase NA Unknown
162 enrolled

Disease, Musculoskeletal Diseases

NCT02934685 2016-11-18

IG-VMAT for Localized Prostate Cancer

Beijing Hospital

Phase 3 Unknown
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT02484339 2016-04-27

α-RT

University Hospital Freiburg

Phase 2 Unknown
274 enrolled
Genitourinary

Prostatic Neoplasms

NCT01188330 2013-10-31

MLSP

Institut Paoli-Calmettes

Phase NA Unknown
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡